The Novel and Exceptional Technology and Research Advisory Committee (NExTRAC) will hold a virtual meeting to discuss the draft report of the Engaging the Public as Partners in Clinical Research (ENGAGE) Working Group
Draft Report of the Engaging the Public as Partners in Clinical Research (ENGAGE) Working Group
NExTRAC Meeting Engage Slides Final
The Novel and Exceptional Technology and Research Advisory Committee (NExTRAC) will receive an update from the Working Group on Engaging the Public as Partners in Clinical Research and discuss the next steps regarding the current charge to the committee, delivered in August 2023
https://videocast.nih.gov/watch=55348
NExTRAC December 3, 2024 Agenda
ENGAGE WG Progress Update to the NExTRAC, Suzanne Bakken and Christin Veasley, December 3, 2024
Any interested person may file written comments by forwarding the statement to [email protected] at least two business days prior to the meeting date. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Other than name and contact information, please do not include any personally identifiable information or any information that you do not wish to make public. Proprietary, classified, confidential, or sensitive information should not be included in your comments. Please note that any comments NIH receives may be posted unredacted to the Office of Science Policy website.
The Novel and Exceptional Technology and Research Advisory Committee (NExTRAC) will receive an update from the Working Group on Engaging the Public as Partners in Clinical Research and discuss the next steps regarding the current charge to the committee, delivered in August 2023 (Federal Register Notice).
Registration is not required to view the webcast.
The materials below contain content that is not fully supported by assistive technology. For accessibility assistance with these files, please contact: [email protected].
https://videocast.nih.gov/watch=54917
Final Approved Meeting Minutes
Any interested person may file written comments by e-mailing [email protected] at least two business days prior to the meeting date. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Other than name and contact information, please do not include any personally identifiable information or any information that you do not wish to make public. Proprietary, classified, confidential, or sensitive information should not be included in your comments. Please note that any comments NIH receives may be posted unredacted to the Office of Science Policy website.
The Novel and Exceptional Technology and Research Advisory Committee (NExTRAC) will hold a virtual meeting to discuss the draft report of the Working Group on Data Science and Emerging Technology. In addition, the meeting will include a discussion of next steps for the Committee (Federal Register notice).
Registration is not required to view the webcast.
The materials below contain content that is not fully supported by assistive technology. For accessibility assistance with these files, please contact: [email protected].
https://videocast.nih.gov/watch=52218
NExTRAC August 29, 2023 Agenda
NIH NExTRAC August 29, 2023 Meeting Minutes
Draft Report of the NExTRAC WG on Data Science and Emerging Technology*
*Note: The NExTRAC working group’s report is a draft, pre-decisional document. The NExTRAC publicly discussed and endorsed the draft findings and recommendations with minor modifications to the report at the August 29, 2023 meeting. The final NExTRAC report was transmitted to the Acting NIH Director and can be found here.
Members of the public may request to make an oral public comment or may submit written public comments. To sign up to make an oral public comment, please submit your name, affiliation, and short description of the oral comment to [email protected] by August 25, 2023. Once all time slots are filled, only written comments will be accepted.
Any interested person may file written comments by e-mailing [email protected] by August 25, 2023. The statement should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person. Other than name and contact information, please do not include any personally identifiable information or any information that you do not wish to make public. Proprietary, classified, confidential, or sensitive information should not be included in your comments. Please note that any comments NIH receives may be posted unredacted to the Office of Science Policy website.
Presentation – Draft Report of the Working Group on Data Science and Emerging Technology
Presentation – ENGAGE Charge to the NExTRAC
